Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 4
2007 3
2008 3
2009 3
2010 4
2011 4
2012 2
2013 2
2014 3
2015 4
2016 1
2017 3
2018 4
2019 2
2020 4
2021 4
2022 9
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Detection and genome characterisation of SARS-CoV-2 P.6 lineage in dogs and cats living with Uruguayan COVID-19 patients.
Panzera Y, Mirazo S, Baz M, Techera C, Grecco S, Cancela F, Fuques E, Condon E, Calleros L, Camilo N, Fregossi A, Vaz I, Pessina P, Deshpande N, Pérez R, Benech A. Panzera Y, et al. Among authors: baz m. Mem Inst Oswaldo Cruz. 2023 Jan 16;117:e220177. doi: 10.1590/0074-02760220177. eCollection 2023. Mem Inst Oswaldo Cruz. 2023. PMID: 36651456 Free PMC article.
Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine.
Nantel S, Bourdin B, Adams K, Carbonneau J, Rabezanahary H, Hamelin MÈ, McCormack D, Savard P, Longtin Y, Cheng MP, De Serres G, Corbeil J, Gilca V, Baz M, Boivin G, Quach C, Decaluwe H. Nantel S, et al. Among authors: baz m. Front Immunol. 2022 Oct 14;13:930252. doi: 10.3389/fimmu.2022.930252. eCollection 2022. Front Immunol. 2022. PMID: 36311736 Free PMC article.
Cross-reactive immunity against SARS-CoV-2 N protein in Central and West Africa precedes the COVID-19 pandemic.
Pedersen J, Koumakpayi IH, Babuadze G, Baz M, Ndiaye O, Faye O, Diagne CT, Dia N, Naghibosadat M, McGeer A, Muberaka S, Moukandja IP, Ndidi S, Tauil CB, Lekana-Douki JB, Loucoubar C, Faye O, Sall A, Magalhães KG, Weis N, Kozak R, Kobinger GP, Fausther-Bovendo H. Pedersen J, et al. Among authors: baz m. Sci Rep. 2022 Jul 28;12(1):12962. doi: 10.1038/s41598-022-17241-9. Sci Rep. 2022. PMID: 35902675 Free PMC article.
A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection.
Olivera-Ugarte SM, Bolduc M, Laliberté-Gagné MÈ, Blanchette LJ, Garneau C, Fillion M, Savard P, Dubuc I, Flamand L, Farnòs O, Xu X, Kamen A, Gilbert M, Rabezanahary H, Scarrone M, Couture C, Baz M, Leclerc D. Olivera-Ugarte SM, et al. Among authors: baz m. Nanomedicine. 2022 Aug;44:102584. doi: 10.1016/j.nano.2022.102584. Epub 2022 Jul 16. Nanomedicine. 2022. PMID: 35850421 Free PMC article.
54 results